News1 min read
Virginia invests nearly $15 million to expand Medicaid access to sickle cell gene therapies
About this article
- Published
- Last updated
- Further reading
- Read More(opens in a new tab)

Gene therapy is offering new hope for people with sickle cell disease. Here's how Virginia's latest Medicaid funding could expand access to treatment.
NORFOLK, Va. — 42-year-old Santino Blow said years of painful complications from sickle cell disease have left little room for making memories.
When 13News Now met Blow at Sentara Leigh Hospital in Norfolk, he was five days into yet another hospital stay. It came just weeks after a seven-day admission and only months after another hospitalization that lasted two weeks.